Unlocking the Promise of Personalized Medicine: Perspectives on Reimbursement, Coverage, and Clinical Utility
The promise of personalized medicine holds allure for patients, providers, and payers alike by improving quality of care by targeting therapy, predicting disease course, mitigating risk, and reducing waste of scarce resources. For manufacturers, navigating the path to commercialization for personalized medicine is filled with barriers which hinder adoption of personalized medicine across the globe, including industry incentive, regulatory pathways, reimbursement policies, and physician habits. AmerisouceBergen addresses these barriers in our latest white paper, Unlocking the Promise of Personalized Medicine: Perspectives on Reimbursement, Coverage, and Clinical Utility. The paper will explore the role of personalized medicine in today’s healthcare system with an overview of payer perspectives.